open access

Ahead of Print
Letter to the Editor
Published online: 2021-10-13
Submitted: 2021-05-06
Accepted: 2021-06-26
Get Citation

Inhaled budesonide for mild COVID-19. Is there more to it than just airways?

Sahaj Rathi1, Pranav Ish2, Ashwini Kalantri3, Shriprakash Kalantri3
DOI: 10.5603/ARM.a2021.0082
·
Pubmed: 34668186
Affiliations
  1. Post Graduate Institute of Medical Education and Research, Chandigarh, India
  2. Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
  3. Mahatma Gandhi Institue of Medical Sciences, Sevagram, Maharasthra, India

open access

Ahead of Print
LETTERS
Published online: 2021-10-13
Submitted: 2021-05-06
Accepted: 2021-06-26

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

COVID-19; budesonide; airways; benefit

Supp./Additional Files (1)
author details and first page file
Download
13KB
About this article
Title

Inhaled budesonide for mild COVID-19. Is there more to it than just airways?

Journal

Advances in Respiratory Medicine

Issue

Ahead of Print

Article type

Letter to the Editor

Published online

2021-10-13

DOI

10.5603/ARM.a2021.0082

Pubmed

34668186

Keywords

COVID-19
budesonide
airways
benefit

Authors

Sahaj Rathi
Pranav Ish
Ashwini Kalantri
Shriprakash Kalantri

References (4)
  1. Ramakrishnan S, Nicolau D, Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. The Lancet Respiratory Medicine. 2021; 9(7): 763–772.
  2. Rothwell JC, Julious SA, Cooper CL. A study of target effect sizes in randomised controlled trials published in the Health Technology Assessment journal. Trials. 2018; 19(1): 544.
  3. The Rime of the Ancient Mariner (text of 1834). https://www.poetryfoundation.org/poems/43997/the-rime-of-the-ancient-mariner-text-of-1834 (May 5, 2021).
  4. Siemieniuk RAc, Bartoszko JJ, Ge L, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020; 370: m2980.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl